Total Assets$XTALPI(02228.HK) XtalPi (2228.HK) has announced that its solid-state research and development team was invited to contribute to the fourth edition of the international authoritative pharmacology monograph "Comprehensive Medicinal Chemistry." The team authored Chapter 2.24, "Prediction of small molecule crystal structures." This content was publicly released by the leading global academic publisher Elsevier in April 2026. This invitation to contribute fully demonstrates the high recognition from the global academic and pharmaceutical industries for XtalPi's technological leadership, industrial application capabilities, and outstanding contributions in the field of Crystal Structure Prediction (CSP). It marks a significant milestone for the company, as its solid-state R&D technology has received authoritative endorsement from industry, academia, and research institutions.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
